Dave Vigerust, MS, Ph.D

Experience

Dr. Vigerust is the Director of Clinical Affairs and molecular scientist for a diagnostics laboratory focused around precision medicine, genomics and infectious disease. Dr. Vigerust has published extensively in international journals, presented his research at national and international conferences and is an active editor and reviewer for several prominent journals.

Dr. Vigerust has developed several novel molecular diagnostic assays for the prediction of cardiovascular risk in patients with diabetes, infectious disease and cancer. Dr. Vigerust currently maintains an Adjunct Assistant Professor position at Vanderbilt University Medical Center in the Department of Neurological Surgery and a Clinical Assistant Professor position with the University of Maryland, Eastern Shore School of Pharmacy.

Education

Post-doctorate:

Vanderbilt University School of Medicine, 2007-2009.
Department of Pediatrics, Program in Vaccine Sciences.
Nashville, Tennessee 37232.
‍
St. Jude Children’s Research Hospital, 2004-2007.
Department of Infectious Diseases.
Memphis, Tennessee38105.
‍

Doctorate:

Vanderbilt University School of Medicine.
Nashville,Tennessee 37212
Degree- Ph. D (Cellular and Molecular Pathology), 2004.
‍

Masters:

Texas Tech University. Lubbock, Texas 79409
Degree- M.S. (Microbiology/ Immunology), 1999.

Arizona State University.
Tempe, AZ 85001 Degree- M.S. (Biomedical Diagnostics), 2021.

‍
Undergraduate:

University of Texas at El Paso.
El Paso, TX 79925 Degree- B.S. (Biology), 1992.

View Google Scholar profile

Expertise

Dr. Vigerust’s academic and research interests focus around areas of precision medicine, diagnostics, infectious disease, traumatic brain injury, and neuroinflammation.

He has a particular interest in the role of neuroinflammation in the development of meningioma. He also has a significant research and clinical interest in respiratory and wound infectious disease.